CN102952787A - Acetylxylan esterase and application thereof - Google Patents
Acetylxylan esterase and application thereof Download PDFInfo
- Publication number
- CN102952787A CN102952787A CN2012104036662A CN201210403666A CN102952787A CN 102952787 A CN102952787 A CN 102952787A CN 2012104036662 A CN2012104036662 A CN 2012104036662A CN 201210403666 A CN201210403666 A CN 201210403666A CN 102952787 A CN102952787 A CN 102952787A
- Authority
- CN
- China
- Prior art keywords
- xylan esterase
- acetyl xylan
- esterase
- ala
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010080434 cephalosporin-C deacetylase Proteins 0.000 title claims abstract description 109
- 108010093941 acetylxylan esterase Proteins 0.000 title claims abstract description 108
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 claims abstract description 17
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 13
- 150000004666 short chain fatty acids Chemical class 0.000 claims abstract description 11
- 230000007062 hydrolysis Effects 0.000 claims abstract description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 238000005917 acylation reaction Methods 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 230000010933 acylation Effects 0.000 claims description 17
- 239000013604 expression vector Substances 0.000 claims description 11
- 230000000694 effects Effects 0.000 abstract description 47
- 108090000371 Esterases Proteins 0.000 abstract description 29
- -1 acyl saccharides Chemical class 0.000 abstract description 16
- 108020004414 DNA Proteins 0.000 abstract description 13
- 239000002773 nucleotide Substances 0.000 abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 6
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract description 4
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 abstract description 4
- 239000000543 intermediate Substances 0.000 abstract description 4
- 239000002132 β-lactam antibiotic Substances 0.000 abstract description 4
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 102000053602 DNA Human genes 0.000 abstract 3
- 238000010367 cloning Methods 0.000 abstract 1
- 239000013599 cloning vector Substances 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 description 72
- 102000004190 Enzymes Human genes 0.000 description 72
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 35
- 239000000243 solution Substances 0.000 description 35
- 239000007788 liquid Substances 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 23
- 241000894006 Bacteria Species 0.000 description 20
- 238000001962 electrophoresis Methods 0.000 description 14
- 230000031700 light absorption Effects 0.000 description 13
- 229920001221 xylan Polymers 0.000 description 13
- 229930186147 Cephalosporin Natural products 0.000 description 12
- 229960000583 acetic acid Drugs 0.000 description 12
- 239000000872 buffer Substances 0.000 description 12
- 229940124587 cephalosporin Drugs 0.000 description 12
- 150000001780 cephalosporins Chemical class 0.000 description 12
- 101150023090 CAH gene Proteins 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 241000193830 Bacillus <bacterium> Species 0.000 description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- RJNPPEUAJCEUPV-UHFFFAOYSA-N naphthalen-2-yl acetate Chemical compound C1=CC=CC2=CC(OC(=O)C)=CC=C21 RJNPPEUAJCEUPV-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 150000001272 acylglucoses Chemical class 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 241000282326 Felis catus Species 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
- 244000063299 Bacillus subtilis Species 0.000 description 7
- 235000014469 Bacillus subtilis Nutrition 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 238000002523 gelfiltration Methods 0.000 description 7
- 238000010353 genetic engineering Methods 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 150000003952 β-lactams Chemical class 0.000 description 7
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 6
- 125000004494 ethyl ester group Chemical group 0.000 description 6
- 108010036413 histidylglycine Proteins 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 238000013016 damping Methods 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- VGKONPUVOVVNSU-UHFFFAOYSA-N naphthalen-1-yl acetate Chemical compound C1=CC=C2C(OC(=O)C)=CC=CC2=C1 VGKONPUVOVVNSU-UHFFFAOYSA-N 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 150000004823 xylans Chemical class 0.000 description 5
- 229960003487 xylose Drugs 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 241000003114 Bacillus velezensis FZB42 Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 4
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical class C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 3
- 150000004782 1-naphthols Chemical class 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 229920002488 Hemicellulose Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 108010013043 Acetylesterase Proteins 0.000 description 2
- DKJPOZOEBONHFS-ZLUOBGJFSA-N Ala-Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O DKJPOZOEBONHFS-ZLUOBGJFSA-N 0.000 description 2
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 2
- KMGOBAQSCKTBGD-DLOVCJGASA-N Ala-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CN=CN1 KMGOBAQSCKTBGD-DLOVCJGASA-N 0.000 description 2
- LNNSWWRRYJLGNI-NAKRPEOUSA-N Ala-Ile-Val Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O LNNSWWRRYJLGNI-NAKRPEOUSA-N 0.000 description 2
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 2
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 2
- RAAWHFXHAACDFT-FXQIFTODSA-N Ala-Met-Asn Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(O)=O RAAWHFXHAACDFT-FXQIFTODSA-N 0.000 description 2
- XAXHGSOBFPIRFG-LSJOCFKGSA-N Ala-Pro-His Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O XAXHGSOBFPIRFG-LSJOCFKGSA-N 0.000 description 2
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 2
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 2
- AOAKQKVICDWCLB-UWJYBYFXSA-N Ala-Tyr-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N AOAKQKVICDWCLB-UWJYBYFXSA-N 0.000 description 2
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 2
- NLYYHIKRBRMAJV-AEJSXWLSSA-N Ala-Val-Pro Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N NLYYHIKRBRMAJV-AEJSXWLSSA-N 0.000 description 2
- PEFFAAKJGBZBKL-NAKRPEOUSA-N Arg-Ala-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PEFFAAKJGBZBKL-NAKRPEOUSA-N 0.000 description 2
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 2
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 2
- AYOAHKWVQLNPDM-HJGDQZAQSA-N Asn-Lys-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AYOAHKWVQLNPDM-HJGDQZAQSA-N 0.000 description 2
- RAUPFUCUDBQYHE-AVGNSLFASA-N Asn-Phe-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RAUPFUCUDBQYHE-AVGNSLFASA-N 0.000 description 2
- SOYOSFXLXYZNRG-CIUDSAMLSA-N Asp-Arg-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O SOYOSFXLXYZNRG-CIUDSAMLSA-N 0.000 description 2
- RPUYTJJZXQBWDT-SRVKXCTJSA-N Asp-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N RPUYTJJZXQBWDT-SRVKXCTJSA-N 0.000 description 2
- KOWYNSKRPUWSFG-IHPCNDPISA-N Asp-Phe-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)NC(=O)[C@H](CC(=O)O)N KOWYNSKRPUWSFG-IHPCNDPISA-N 0.000 description 2
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 2
- XWKBWZXGNXTDKY-ZKWXMUAHSA-N Asp-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O XWKBWZXGNXTDKY-ZKWXMUAHSA-N 0.000 description 2
- 241000194103 Bacillus pumilus Species 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- LGIKBBLQVSWUGK-DCAQKATOSA-N Gln-Leu-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LGIKBBLQVSWUGK-DCAQKATOSA-N 0.000 description 2
- IULKWYSYZSURJK-AVGNSLFASA-N Gln-Leu-Lys Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O IULKWYSYZSURJK-AVGNSLFASA-N 0.000 description 2
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 2
- VGUYMZGLJUJRBV-YVNDNENWSA-N Glu-Ile-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O VGUYMZGLJUJRBV-YVNDNENWSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- XBWMTPAIUQIWKA-BYULHYEWSA-N Gly-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN XBWMTPAIUQIWKA-BYULHYEWSA-N 0.000 description 2
- VOCMRCVMAPSSAL-IUCAKERBSA-N Gly-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CN VOCMRCVMAPSSAL-IUCAKERBSA-N 0.000 description 2
- ALOBJFDJTMQQPW-ONGXEEELSA-N Gly-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)CN ALOBJFDJTMQQPW-ONGXEEELSA-N 0.000 description 2
- UESJMAMHDLEHGM-NHCYSSNCSA-N Gly-Ile-Leu Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O UESJMAMHDLEHGM-NHCYSSNCSA-N 0.000 description 2
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 2
- CSMYMGFCEJWALV-WDSKDSINSA-N Gly-Ser-Gln Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O CSMYMGFCEJWALV-WDSKDSINSA-N 0.000 description 2
- IROABALAWGJQGM-OALUTQOASA-N Gly-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)CN IROABALAWGJQGM-OALUTQOASA-N 0.000 description 2
- UIQGJYUEQDOODF-KWQFWETISA-N Gly-Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 UIQGJYUEQDOODF-KWQFWETISA-N 0.000 description 2
- YJDALMUYJIENAG-QWRGUYRKSA-N Gly-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN)O YJDALMUYJIENAG-QWRGUYRKSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- ZJSMFRTVYSLKQU-DJFWLOJKSA-N His-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N ZJSMFRTVYSLKQU-DJFWLOJKSA-N 0.000 description 2
- FIMNVXRZGUAGBI-AVGNSLFASA-N His-Glu-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FIMNVXRZGUAGBI-AVGNSLFASA-N 0.000 description 2
- WGHJXSONOOTTCZ-JYJNAYRXSA-N His-Glu-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WGHJXSONOOTTCZ-JYJNAYRXSA-N 0.000 description 2
- OQDLKDUVMTUPPG-AVGNSLFASA-N His-Leu-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OQDLKDUVMTUPPG-AVGNSLFASA-N 0.000 description 2
- DQZCEKQPSOBNMJ-NKIYYHGXSA-N His-Thr-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DQZCEKQPSOBNMJ-NKIYYHGXSA-N 0.000 description 2
- HDODQNPMSHDXJT-GHCJXIJMSA-N Ile-Asn-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O HDODQNPMSHDXJT-GHCJXIJMSA-N 0.000 description 2
- UMYZBHKAVTXWIW-GMOBBJLQSA-N Ile-Asp-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N UMYZBHKAVTXWIW-GMOBBJLQSA-N 0.000 description 2
- NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 description 2
- RVNOXPZHMUWCLW-GMOBBJLQSA-N Ile-Met-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)O)N RVNOXPZHMUWCLW-GMOBBJLQSA-N 0.000 description 2
- SVZFKLBRCYCIIY-CYDGBPFRSA-N Ile-Pro-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVZFKLBRCYCIIY-CYDGBPFRSA-N 0.000 description 2
- CAHCWMVNBZJVAW-NAKRPEOUSA-N Ile-Pro-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)N CAHCWMVNBZJVAW-NAKRPEOUSA-N 0.000 description 2
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- SUPVSFFZWVOEOI-UHFFFAOYSA-N Leu-Ala-Tyr Natural products CC(C)CC(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-UHFFFAOYSA-N 0.000 description 2
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 2
- HVJVUYQWFYMGJS-GVXVVHGQSA-N Leu-Glu-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O HVJVUYQWFYMGJS-GVXVVHGQSA-N 0.000 description 2
- HDHQQEDVWQGBEE-DCAQKATOSA-N Leu-Met-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O HDHQQEDVWQGBEE-DCAQKATOSA-N 0.000 description 2
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 2
- MVHXGBZUJLWZOH-BJDJZHNGSA-N Leu-Ser-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVHXGBZUJLWZOH-BJDJZHNGSA-N 0.000 description 2
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 2
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 2
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 2
- HQVDJTYKCMIWJP-YUMQZZPRSA-N Lys-Asn-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HQVDJTYKCMIWJP-YUMQZZPRSA-N 0.000 description 2
- KWUKZRFFKPLUPE-HJGDQZAQSA-N Lys-Asp-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWUKZRFFKPLUPE-HJGDQZAQSA-N 0.000 description 2
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 2
- PSVAVKGDUAKZKU-BZSNNMDCSA-N Lys-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCCN)N)O PSVAVKGDUAKZKU-BZSNNMDCSA-N 0.000 description 2
- VOOINLQYUZOREH-SRVKXCTJSA-N Met-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N VOOINLQYUZOREH-SRVKXCTJSA-N 0.000 description 2
- IHRFZLQEQVHXFA-RHYQMDGZSA-N Met-Thr-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCCN IHRFZLQEQVHXFA-RHYQMDGZSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 2
- VJLLEKDQJSMHRU-STQMWFEESA-N Phe-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O VJLLEKDQJSMHRU-STQMWFEESA-N 0.000 description 2
- LRBSWBVUCLLRLU-BZSNNMDCSA-N Phe-Leu-Lys Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O LRBSWBVUCLLRLU-BZSNNMDCSA-N 0.000 description 2
- OXKJSGGTHFMGDT-UFYCRDLUSA-N Phe-Phe-Arg Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 OXKJSGGTHFMGDT-UFYCRDLUSA-N 0.000 description 2
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 2
- FFSLAIOXRMOFIZ-GJZGRUSLSA-N Pro-Gly-Trp Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)CNC(=O)[C@@H]1CCCN1 FFSLAIOXRMOFIZ-GJZGRUSLSA-N 0.000 description 2
- YTWNSIDWAFSEEI-RWMBFGLXSA-N Pro-His-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)O YTWNSIDWAFSEEI-RWMBFGLXSA-N 0.000 description 2
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 2
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 2
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- BSXKBOUZDAZXHE-CIUDSAMLSA-N Ser-Pro-Glu Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O BSXKBOUZDAZXHE-CIUDSAMLSA-N 0.000 description 2
- QPPYAWVLAVXISR-DCAQKATOSA-N Ser-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QPPYAWVLAVXISR-DCAQKATOSA-N 0.000 description 2
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000203780 Thermobifida fusca Species 0.000 description 2
- MQBTXMPQNCGSSZ-OSUNSFLBSA-N Thr-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N MQBTXMPQNCGSSZ-OSUNSFLBSA-N 0.000 description 2
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 2
- CJEHCEOXPLASCK-MEYUZBJRSA-N Thr-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=C(O)C=C1 CJEHCEOXPLASCK-MEYUZBJRSA-N 0.000 description 2
- SPIFGZFZMVLPHN-UNQGMJICSA-N Thr-Val-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SPIFGZFZMVLPHN-UNQGMJICSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- RCLOWEZASFJFEX-KKUMJFAQSA-N Tyr-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RCLOWEZASFJFEX-KKUMJFAQSA-N 0.000 description 2
- BSCBBPKDVOZICB-KKUMJFAQSA-N Tyr-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BSCBBPKDVOZICB-KKUMJFAQSA-N 0.000 description 2
- LMKKMCGTDANZTR-BZSNNMDCSA-N Tyr-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LMKKMCGTDANZTR-BZSNNMDCSA-N 0.000 description 2
- OKDNSNWJEXAMSU-IRXDYDNUSA-N Tyr-Phe-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 OKDNSNWJEXAMSU-IRXDYDNUSA-N 0.000 description 2
- VPEFOFYNHBWFNQ-UFYCRDLUSA-N Tyr-Pro-Tyr Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 VPEFOFYNHBWFNQ-UFYCRDLUSA-N 0.000 description 2
- RMRFSFXLFWWAJZ-HJOGWXRNSA-N Tyr-Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 RMRFSFXLFWWAJZ-HJOGWXRNSA-N 0.000 description 2
- NMPXRFYMZDIBRF-ZOBUZTSGSA-N Val-Asn-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N NMPXRFYMZDIBRF-ZOBUZTSGSA-N 0.000 description 2
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 2
- UKEVLVBHRKWECS-LSJOCFKGSA-N Val-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)N UKEVLVBHRKWECS-LSJOCFKGSA-N 0.000 description 2
- VPGCVZRRBYOGCD-AVGNSLFASA-N Val-Lys-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O VPGCVZRRBYOGCD-AVGNSLFASA-N 0.000 description 2
- JXCOEPXCBVCTRD-JYJNAYRXSA-N Val-Tyr-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N JXCOEPXCBVCTRD-JYJNAYRXSA-N 0.000 description 2
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000003855 acyl compounds Chemical class 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 2
- 108010020688 glycylhistidine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010018006 histidylserine Proteins 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010012058 leucyltyrosine Proteins 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 108010064235 lysylglycine Proteins 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000001426 native polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229940005654 nitrite ion Drugs 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 108010024607 phenylalanylalanine Proteins 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 108010035322 rhamnogalacturonan acetylesterase Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 108010073969 valyllysine Proteins 0.000 description 2
- NVIAYEIXYQCDAN-MHTLYPKNSA-N (6r,7s)-7-azaniumyl-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound S1CC(C)=C(C([O-])=O)N2C(=O)[C@H]([NH3+])[C@@H]12 NVIAYEIXYQCDAN-MHTLYPKNSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 1
- 150000004786 2-naphthols Chemical class 0.000 description 1
- VIBOGIYPPWLDTI-UHFFFAOYSA-N 2-naphthylacetic acid Chemical class C1=CC=CC2=CC(CC(=O)O)=CC=C21 VIBOGIYPPWLDTI-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 108010051152 Carboxylesterase Proteins 0.000 description 1
- 102000013392 Carboxylesterase Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 241001291204 Thermobacillus Species 0.000 description 1
- 241001647802 Thermobifida Species 0.000 description 1
- 241000999856 Thermotoga maritima MSB8 Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019395 ammonium persulphate Nutrition 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 108010038658 exo-1,4-beta-D-xylosidase Proteins 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- WYMSBXTXOHUIGT-UHFFFAOYSA-N paraoxon Chemical group CCOP(=O)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 WYMSBXTXOHUIGT-UHFFFAOYSA-N 0.000 description 1
- 229960004623 paraoxon Drugs 0.000 description 1
- 229940049547 paraxin Drugs 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses DNA (Deoxyribose Nucleic Acid) of a novel acetylxylan esterase, which has a nucleotide sequence shown as SEQ AXENO.1 and an amino acid sequence shown as SEQAXENO.2. Highest activity is obtained when a protein structure is a homotrimer. The invention also discloses a cloning vector containing the DNA of the novel acetylxylan esterase, a cloning technology and application of a recombinant esterase to hydrolysis of a short-chain fatty acid and acyl saccharides and application of the recombinant esterase to production of deacetylated 7-aminocephalosporanic acid and deacetylated cephalosporin C which are important intermediates of beta-lactam antibiotics; and the novel acetylxylan esterase has an important industrial application value.
Description
Technical field
The invention belongs to gene engineering technology field, be specifically related to a kind of from subtilis (
Bacillus subtilis) in the novel esterases that obtains and expression vector, Recombinant esterase and Recombinant esterase in the 7-amino-cephalosporanic acid of the important intermediate-removal of acylation of hydrolysis short chain fatty acid fat, removal of acylation reaction and β-lactam antibitics and the application among the deacylated cephaloporins C.
Background technology
Acetyl xylan esterase (acetyl xylan esterase; abbreviation AXE) be that a class can and discharge the esterase of acetic acid with the xylopyranose removal of acylation of the acylations in xylan or the xylo-oligosaccharide; classify in Procaine esterase family 7; can be hydrolyzed short chain fatty acid and various acylations compound, have widely substrate specificity.
Now, acetyl xylan esterase shows huge scientific research value and industrial application value, is mainly reflected in following two aspects.On the one hand, acetyl xylan esterase plays an important role in the degraded of hemicellulose xylan.This enzyme and inscribe β-1; 4-zytase, β-D-xylosidase, α-L furan type arabinofuranosidase/xylosidase and α-glucose aldehydic acid enzyme consist of xylanolytic enzyme system together; can be hydrolyzed the hemicellulose xylan with complex construction; so that the inexhaustible renewable resources of development and utilization occurring in nature becomes possibility, the structure and function that obtains in recent years the ethanoyl xylan esterase of high vigor and resolve this enzyme has become the focus of research.On the other hand, it is active that acetyl xylan esterase has good arylsterase, can catalysis 7-amino-cephalosporanic acid and the synthetic β-lactam antibitics parent nucleus of cephalosporin deacylated tRNA base, have huge industrial application value.Beta-lactam antibiotics is one of main type in the microbiotic, and whole world consumption is crossed ten thousand tons.There are the problems such as cost is high, three-waste pollution is serious in the chemical method that uses at present, and the field of much making more and more tends to use enzyme process synthetic.
The gemma quasi-microorganism of the production acetyl xylan esterase of present known report has
Bacillus pumilus, Bacillus subtilisATCC6633
, Bacillus subtilis168,
Bacillus haloduransC-125 etc.Wherein, remove
Bacillus subtilisThe acetyl xylan esterase of ATCC6633 is in the news and has outside the higher pNPA enzyme activity (1580 U/mg), vigor and the performance of the acetyl wood sugar esterase of other bacterial strains are still relatively poor, have limited its widespread use in hemicellulose degraded and the synthetic beta-lactam antibiotics of enzyme process.Therefore, need a kind of highly active acetyl xylan esterase of exploitation, enlarge its use range.
Summary of the invention
Technical purpose of the present invention provides a kind of encoding amino acid sequence and corresponding nucleotide sequence thereof of novel acetyl xylan esterase.
Second technical purpose of the present invention provides the protein structure of acetyl xylan esterase, and be wherein, the highest with the activity of homo-hexamer.
The 3rd technical purpose of the present invention provides the expression vector of the encoding gene that comprises acetyl xylan esterase.
The 4th technical purpose of the present invention provides the method for preparing the acetyl xylan esterase of recombinating.
The 5th technical purpose of the present invention provides the restructuring acetyl xylan esterase in hydrolysis short chain fatty acid fat, removal of acylation reaction, the 7-amino-cephalosporanic acid of producing removal of acylation and the application among the deacylated cephaloporins C.
The present invention is achieved through the following technical solutions:
The present invention utilizes round pcr to amplify the Cah gene from the subtilis genomic dna, and the Cah gene is connected in expression vector pET22b multiple clone site place, obtains recombinant plasmid pET-Cah, recombinant plasmid pET-Cah is transformed again
E. coliBL21 (DE3), the intestinal bacteria that obtain recombinating namely produce the genetic engineering bacterium of acetyl xylan esterase
E. coliBL21
-PET-Cah.
Use the IPTG abduction delivering after the strain culturing, produce the restructuring acetyl xylan esterase, the restructuring acetyl xylan esterase is separated getting final product.Embodiment 1 and embodiment 2 are seen in detailed operating process.
According to technical scheme of the present invention, can reach good technique effect:
One, acetyl xylan esterase sequence of the present invention and bacillus amyloliquefaciens FZB42(GenBank:YP 001419972.1) the sequence homology of acetyl xylan esterase be 99%, have 10 bases, 2 amino acid to be different from the ethanoyl xylan esterase gene of bacillus amyloliquefaciens FZB42: the 240th L-Ala (A) by the GCC coding of amino acid position replaces with the Threonine (T) of ACC or ACA or ACG coding; 289 amino acids are replaced with the glutamine (Q) of CAA or CAG coding by the L-glutamic acid (E) of GAA coding.In addition, acetyl xylan esterase of the present invention with characterized
Bacillus subtilis168(GenBank:NP_388200.1),
Bacillus subtilisATCC6633(GenBank:ZP_06875135.1),
Bacillus pumilusCect5072(GenBank:2XLC_A) acetyl xylan esterase homology is respectively 84%, 84%, 73%; With
Thermobacillus compostiAcetyl xylan esterase (GenBank:ZP_08919340.1) homology is 59%, with
Thermotoga maritimaMSB8 acetyl wood sugar esterase (GenBank:NP_227893.1) homology 41%, with
Bacillus haloduransCephalosporin desaturase (GenBank:BAB07045.1) homology 35% of C-125.
Above-mentioned restructuring acetyl xylan esterase is carried out abduction delivering, obtained the aminoacid sequence shown in SEQ ID No:2.In the present invention, the nucleotide sequence that this aminoacid sequence is corresponding is shown in SEQ ID No:1.But; according to those skilled in the art's common practise as can be known; the coding of Nucleotide codon of an amino-acid residue of can encoding may have at least a; perhaps two kinds and more than; therefore; the protection domain of acetyl xylan esterase of the present invention should at first be as the criterion based on the aminoacid sequence shown in the SEQ ID No:2; its extended protection scope is any nucleotide sequence of the aminoacid sequence shown in the SEQ ID No:2 of can encoding out, and is not limited to the sequence shown in the nucleotide sequence shown in the SEQ ID No:1.
Two, acetyl xylan esterase of the present invention (AXE), its protein structure is homo-hexamer, but depolymerization is homotrimer, and homotrimer has certain activity.
Restructuring acetyl xylan esterase monomer molecule amount of the present invention is 36 kDa, and the tripolymer molecular weight is 107 kDa, and six polymer molecular amounts are 216 kDa.Acetyl xylan esterase is homo-hexamer under the state of nature, under 1% SDS effect, can depolymerization be homotrimer, and when existing without SDS, the rapid autohemagglutination of tripolymer is combined into six aggressiveness, and recovers the high reactivity of six aggressiveness.The prior art report
Bacillus subtilis168 and bacillus pumilus acetyl xylan esterase state of nature under also be homo-hexamer, molecular weight is respectively 220 kDa and 190 kDa, but its tripolymer existence form has no report.(Multifunctional Xylooligosaccharide/Cephalosporin C Deacetylase Revealed by the Hexameric Structure of the Bacillus subtilis Enzyme at 1.9 A Resolution. Florence Vincent, Simon J et al. 2003. J. Mol. Biol. (2003) 330, 593-606;The crystal structure of the cephalosporin deacetylating enzyme acetyl xylan esterase bound to paraoxon explains the low sensitivity of this serine hydrolase to organophosphate inactivation. Silvia Montoro-Garcia, Fernando Gil-Ortiz et al. 2011.Biochem. J 436,321-330)。
Bacillus subtilisThe acetyl xylan esterase of ATCC6633 is single aggressiveness, and molecular weight is 37 kDa(YesT:A new rhamnogalacturonan acetyl esterase from
Bacillus subtilis.Irene Martinez-Martinez, Jose Navarro-Fernandez et al. Proteins 2008; 71:379 – 388.).
Bacillus haloduransThe cephalosporin desaturase of C-125 is single aggressiveness, and molecular weight is 45kDa(Characterization of a New C-125 Rhamnogalacturonan Acetyl Esterase from
Bacillus haloduransWith a New Putative Carbohydrate Binding Domain. Jose Navarro-Fernandez, Irene Martinez-Martinez et al. J. Bacteriol.2008,190 (4): 1375.).
The dna sequence dna efficient soluble expression restructuring acetyl xylan esterase in Escherichia coli system that derives from subtilis of the present invention has widely substrate spectrum, can be hydrolyzed short chain fatty acid fat and multiple acylations compound.Original pNPA enzyme activity is 383.3 U/mL behind the broken born of the same parents of restructuring acetyl xylan esterase of the present invention; PNPA reaches 2950U/mg than vigor behind the partial purification, and the vigor of cephalosporin reaches 640 U/mg, is the high reactivity of the known report of bacillus, sees Table 1.
Restructuring acetyl xylan esterase of the present invention has very strong chain length specificity to the fatty acid ester of C2, and activity had been reduced to 0.09% when chain length increased to C4, rarely seen report.With known report
Thermobifida fuscaAcetyl xylan esterase relatively see Table 2.
Table 2. restructuring acetyl xylan esterase is to the chain length specificity of fatty acid ester
C-2 | C-4 | C-6 | C-8 | C-10 | C16 | |
AXE of the present invention | 705.3 | 0.65 | 0 | 0 | 0 | |
AXE from Thermobifida fusca a | 22 | 8 | -- | 4 | -- | 2 |
[a], Yang, C.-H., & Liu, W.-H. (2008). Purification and properties of an acetylxylan esterase from
Thermobifida fusca. Enzyme and Microbial Technology, 42(2), 181-186.
Three, the present invention's claimed expression vector that comprises the encoding gene of acetyl xylan esterase of the present invention also.According to those skilled in the art's common practise, described expression vector should include but not limited to recombinant vectors, recombinant bacterium, transgenic cell line, expression cassette or recombinant virus; In an embodiment of the present invention, described concrete expression vector is the recombinant vectors that obtains for the multiple clone site with the encoding gene insertion vector pET22b of acetyl xylan esterase of the present invention.
Four, a kind of method for preparing acetyl xylan esterase of the present invention is characterized in that: transform Host Strains with expression vector of the present invention, abduction delivering obtains the restructuring acetyl xylan esterase.
Five, acetyl xylan esterase of the present invention is in hydrolysis short chain fatty acid fat, removal of acylation reaction, the 7-amino-cephalosporanic acid of producing removal of acylation and the application among the deacylated cephaloporins C.
Application of the present invention shows as lives to the high enzyme of present 7-amino-cephalosporanic acid and especially cephalosporin.It is right that Montoro-Garc í a has attempted
B. pumilusBeing fixed of acetyl wood sugar esterase, catalyze and synthesize 7-ADCA and cephalosporin, transformation efficiency reaches 100%(A colorimetric assay for the determination of acetyl xylan esterase or cephalosporin C acetyl esterase activities using 7-amino phalosporanic acid behind the catalyzed reaction 100min, cephalosporin C, or acetylated xylan as substrate. Silvia Montoro-Garc í a, Fernando Gil-Ortiz et al. 2010. Bioresource Technology 101 331-336).And restructuring acetyl xylan esterase of the present invention is higher than far away the activity of 7-amino-cephalosporanic acid and cephalosporin
B. pumilusAcetyl xylan esterase, this demonstrates acetyl xylan esterase of the present invention and have huge application potential in the industry of beta-lactam antibiotics intermediate is synthetic.
Description of drawings
Fig. 1 is the Cah gene fragment that amplifies.Wherein, M:DNA Marker DL5000; 1,2:Cah.
Fig. 2 is Cah and pET22b connection result.Wherein, M:DNA Marker DL5000; 1:pDK7-Nox.
Fig. 3 is the SDS-PAGE gel (coomassie brilliant blue staining) of the acetyl xylan esterase of genetic engineering bacterium expression; Wherein, M: wide molecular weight maker (TaKaRa), the ethanoyl xylan esterase of 1-3 purifying.
Fig. 4 is bovine serum albumin (BSA) concentration-OD595 light absorption value typical curve.
Fig. 5 is p-NP (p-NP) concentration-OD405 light absorption value typical curve.
Fig. 6 is acetate concentration-OD210 light absorption value typical curve.
Fig. 7 is acetyl xylan esterase optimal reactive temperature, pH and the temperature pH stability experiment result of purifying.
Fig. 8 is the SDS-PAGE gel electrophoresis (coomassie brilliant blue staining) of the acetyl xylan esterase of non-depolymerization and depolymerization; Wherein, M: wide molecular weight maker (TaKaRa), 1,2 are respectively the ethanoyl xylan esterase of non-depolymerization and the depolymerization of purifying.
Fig. 9 is the typical curve of 4-methyl umbelliferone concentration-OD354.
Figure 10 is gel-filtration molecular weight standard curve.Wherein, Ve is the sample elution volume, and Vo is void volume.
Figure 11 is that SDS is on the impact of acetyl xylan esterase.Wherein, swimming lane 1 is for adding 0.5% SDS enzyme liquid, and swimming lane 2 is not for adding the enzyme liquid of SDS;
Figure 12 for determine trimerical activity and with the transformation relation of six aggressiveness.
Acetyl xylan esterase engineering strain of the present invention, its Classification And Nomenclature be intestinal bacteria (
Escherichia coli) BL21
-PET-Cah; Its preservation mechanism full name is Chinese Typical Representative culture collection center, is called for short CCTCC, and the address is China. Wuhan. and Wuhan University; Preservation date is on October 17th, 2012, and preserving number is numbered: CCTCC NO:M 2012408.
Embodiment
Bacterial classification used in the present invention source:
1, expresses bacterium
E. coliBL21 (DE3) buys from TaKaRa company.
2, subtilis (
Bacillus subtilis) the gene C ah source of acetyl xylan esterase of CICC 20034: Cah gene (GenBank:ZP_10041520.1) is as template among the bacillus amyloliquefaciens FZB42 that announces take Genebank, and the designed, designed primer obtains behind the pcr amplification.
3, related primer is designed, designed, and entrusts Nanjing Jin Sirui company synthetic.
Below in conjunction with accompanying drawing technical scheme of the present invention is described further, but should not be construed as limitation of the present invention:
The genetic engineering bacterium intestinal bacteria of present embodiment explanation product acetyl xylan esterase (
Escherichia coli) BL21
-The structure of pET-Cah.
The genetic engineering bacterium intestinal bacteria of the described product acetyl xylan esterase of present embodiment (
Escherichia coli) BL21
-PET-Cah, it be with subtilis (
Bacillus subtilis) the gene C ah of acetyl xylan esterase of CICC 20034 transforms by expression vector pET22b
E. coliThe genetic engineering bacterium that BL21 (DE3) obtains.
The construction process of said gene engineering bacteria is: utilize round pcr to amplify the Cah gene from plasmid vector subtilis genomic dna, the Cah gene is connected in expression vector pET22b multiple clone site place, obtain recombinant plasmid pET-Cah, again recombinant plasmid pET-Cah is transformed
E. coliBL21 (DE3), the intestinal bacteria that obtain recombinating namely produce the genetic engineering bacterium of acetyl xylan esterase
E. coliBL21
-PET-Cah.
Above-mentioned construction process specifically may further comprise the steps:
(1) clone of gene C ah:
According to Cah gene (GenBank:ZP_10041520.1) among the bacillus amyloliquefaciens FZB42 of Genebank announcement, sequences Design is closed primer:
P1:5’ TATA
CATATG(
NdeI)CAATTATACGACTTGC 3’(SEQ ID NO:3)。
P2:5’ G
GAATTC(
EcoRI)CTCAGCCTTTCAGATGCGCT 3’(SEQ ID NO:4)。
Restriction enzyme site is introduced respectively at the primer two ends
NdeI and
EcoRI extracts the explanation of test kit (OMEGA company) and extracts the subtilis genomic dna according to genome, finish the PCR reaction take the subtilis genomic dna as template;
The 8 tube reaction systems of PCR are: Buffer 22.5 μ L, ddH
2O 141.3 μ L, MgCl
213.5 μ L, dNTP-mix 18 μ L, primer P1 4.5 μ L, primer P2 4.5 μ L, Taq enzyme 2.7 μ L; After mixing, be divided into 8 pipes, add 2 μ L template DNAs to every pipe again; PCR reaction conditions: 94 ℃ of denaturation 4 min; Carry out 30 circulating reactions: 94 ℃ of sex change 45 s, 54.1 ℃ of annealing 30 s, 72 ℃ are extended 60 s; Last 72 ℃ of insulation 10 min, reaction finishes rear 4 ℃ of preservations, and behind the reaction terminating, 0.8 % agarose gel electrophoresis detects, and the result is as shown in Figure 1; Behind PCR purification kit (TaKaRa company) purifying, be connected with pMD-T Vector carrier, carry out sequencing,
NdeI and
EcoRThe I enzyme is cut restructuring pMD-T Vector carrier, reclaims 957 bp fragments,
NdeI and
EcoRThe I enzyme is cut the pET22b carrier, reclaims the large fragment product, the double digestion product is connected obtain recombinant plasmid pET-Cah under the effect of T4DNA ligase enzyme.
(2) acquisition of recombination engineering bacteria:
Recombinant plasmid pET-Cah is transformed
E. coliBL21 (DE3), coating contains the paraxin flat board of 40 μ g/mL, the picking positive transformant, and carry out bacterium colony PCR and identify, obtain restructuring
E. coli, called after
E. coliBL21pET-Cah extracts
E. coliThe recombinant plasmid of BL21pET-Cah carries out
NdeI and
EcoRI double digestion checking (such as Fig. 2).
The derivational expression method of present embodiment explanation acetyl xylan esterase.
Utilize the concrete scheme of genetic engineering bacterium abduction delivering acetyl xylan esterase of embodiment 1 as follows:
(1) starting strain: intestinal bacteria (
Escherichia coli) BL21
-PET-Cah;
(2) seed culture:
Substratum: LB substratum: yeast powder 5g/L, peptone 10 g/L, sodium-chlor 10 g/L;
Culture condition: 250 mL triangular flasks, liquid amount 50 mL, 37 ℃ of culture temperature, shaking speed 200 r/min cultivate 12 h;
(3) fermentation culture:
Substratum forms: LB substratum: yeast powder 5g/L, peptone 10 g/L, sodium-chlor 10 g/L;
Culture condition: inoculum size 1.5% (v/v), 37 ℃ of leavening temperatures add sec.-propyl-β-D-sulfo-galactopyranoside (IPTG) and induce, final concentration 1.0 mmol/L of IPTG when OD reaches 0.6 ~ 0.8, shaking speed 180 ~ 250 r/min, fermentation 2-10 h.
(4) obtaining of crude enzyme liquid:
Take out fermented liquid, place the 50mL centrifuge tube, 4 ℃, 10000 leave heart 10min, and supernatant discarded adds the Tris-HCl damping fluid of 50mL pH7.4, and thalline is carried out ultrasonication, and broken condition is as follows: 3s work, 3s intermittently, 550w 15min.Broken rear 4 ℃, 10000 leave heart 30min.Supernatant is crude enzyme liquid.
(5) mensuration of enzyme activity:
Use pNPA to be substrate, 1 enzyme unit alive (U) is defined as: under certain reaction conditions, per minute discharges the required enzyme amount of 1 μ L p-NP.
Standard curve making: the preparation of A solution: the phosphoric acid buffer of 50 mmol/L (pH7.0), wherein contain the Sudan Gum-arabic of 0.6% Triton X-100 and 0.1%; The preparation of B solution: accurately take by weighing 0.0139 g pNP reference material, with the dissolving of A solution, volumetric flask is settled to 250 mL, and being made into reference material concentration is the B solution of 1 μ mol/mL.Adopt A solution that B solution is carried out gradient dilution, be made into the pNP solution of different concns.In enzyme plate, add 10 μ L damping fluids, then add successively each 240 μ L of pNP standardized solution of different concns, add A solution in the contrast.Measure 405 nm wavelength place light absorption values with microplate reader.As X-coordinate, as ordinate zou, make typical curve (Fig. 5) with light absorption value with the concentration of pNP.
Determination step is as follows: add 240 μ L substrate solutions (A solution mixes by 9:1 with B solution) in reaction system, 10 μ L are the enzyme liquid of dilution suitably, places water-bath, and temperature is 40 ℃, reaction times 10 min; Use microplate reader to measure light absorption value at 410 nm places.The experiment establish three parallel, average, and use the most control group of 10 μ L distilled water.P-NP typical curve and equation such as Fig. 5.
Measurement result shows: the enzyme liquid of 100 times of dilutions, and light absorption value is respectively under the A410nm: 1.449,1.482,1.509, to calculate by typical curve (Fig. 5), corresponding activity is 224.96U/mL.
(6) mensuration of protein content
Use the Brandford method to measure protein content.
The making of albumen mark song: preparation Xylene Brilliant Cyanine G solution: 100 mg Xylene Brilliant Cyanine G G-250 are dissolved in 50 mL, the 95 % ethanol, add 100 mL, 85 %(v/v again) H
3PO
4, with distilled water diluting to 1 l, can use behind the filter paper filtering at last; Prepare 0.1 g/l BSA: take by weighing 0.01 g BSA, be dissolved in the 10 mL distilled water, be mixed with 0.01,0.02,0.03,0.04,0.06,0.08 mg/mL with physiological saline before using; Get 72 mL centrifuge tubes, the number of finishing (0,1,2,3,4,5,6), in 1 ~ No. 6 centrifuge tube, add respectively above-mentioned dilution after each concentration BSA solution 0.3 mL, in every centrifuge tube, add at last 1.2 mL Xylene Brilliant Cyanine G solution.1.2 mL Xylene Brilliant Cyanine G solution and 0.3 mL physiological saline in No. 0 centrifuge tube.After after each pipe mixes, take No. 0 pipe as blank determination A
595The typical curve that records such as Fig. 4.
The detection concrete steps of albumen are as follows: at first with the concentration of bovine serum albumin (BSA) standard specimen the OD595 light absorption value is made the typical curve equation, such as Fig. 4.Then remove the suitably enzyme liquid 300 μ L of dilution, add 1.2mL Xylene Brilliant Cyanine G working fluid, mixing, room temperature is placed 15min, and measures light absorption value under the 595nm.Do two Duplicate Samples for every group, take distilled water as blank.
Measurement result shows that the reacted OD595 light absorption value of enzyme liquid of 5 times of dilutions is 0.252,0.277.After the typical curve calculating according to Fig. 4, protein concentration is: 0.16 mg/ μ L.Therefore, the ratio enzyme activity of the ethanoyl xylan esterase crude enzyme liquid of engineering bacterium fermentation liquid is 1406 U/mg.
Purifying, molecular weight and the polymer form thereof of present embodiment explanation acetyl xylan esterase.
1. the purifying of acetyl xylan esterase:
Passing through 50%-80%(w/v) ammonium sulfate precipitation and ultrafiltration acetyl xylan esterase concentrate and purifying.Purification step is as follows:
(1) 50%-80% ammonium sulfate precipitation: get broken good solution, 12000g, 30min is centrifugal; Transferase 45 0mL supernatant slowly adds the SAS solution (saturated ammonium sulphate solution) of 50mL while stirring to the 100mL beaker, with solution be placed on the magnetic stirring apparatus stir 6 hours after, be positioned over 4 degree refrigerator overnight and fully precipitate.The centrifugal 30min of protein soln 10000g.The 50mL supernatant is transferred to new beaker, slowly adds while stirring the SAS solution of 75mL, making final concentration is 80% ammoniumsulphate soln, with solution be placed on stir 6 hours on the magnetic stirring apparatus after, be positioned over 4 degree refrigerator overnight and fully precipitate.Behind the centrifugal 30min of protein soln 10000g, abandon filtrate, with the phosphate buffer solution dissolving of precipitation with 5mL pH7.0, again after the solution after the dissolving is transferred to 12h in the dialysis tubing (4 ℃), place the dialysis buffer of 500mL, every 3h changes dialysis buffer liquid once, thoroughly to remove ammonium sulfate.Protein content and enzyme activity behind the mensuration purifying.
(2) gel-filtration: adopt gel-filtration that the acetyl xylan esterase after concentrated is further purified, use HiLoad 16/60 Superdex, 200 gel chromatographic columnses (Healthcare Bio-Sciences company), 50 mM Tris-HCl (comprise 100 mM KCl, pH 7.5) as moving phase, applied sample amount 100 μ L, flow velocity 0.1 mL/min, 280nm detects.Use automatic fraction collector to collect elutriant, the elutriant that the uv-absorbing peak value is arranged is carried out enzyme activity determination, great-hearted part is merged, behind the ultrafiltration and concentration, be pure enzyme liquid.Protein content and enzyme activity behind the mensuration purifying.
Purification effect is as shown in table 3, and the acetyl xylan esterase behind the purifying demonstrates single band, such as Fig. 3.Ethanoyl wood sugar esterase after purified obtains single protein band through the SDS electrophoresis.This shows, the coded polypeptide of the described nucleotide sequence of SEQ ID NO.1 is intestinal bacteria
E. coliEfficiently expressed among the BL21 (DE3), and all recombinant proteins all are soluble, form without inclusion body.
2. acetyl xylan esterase molecular weight and polymer form thereof
The molecular weight under the acetyl xylan esterase state of nature, the purifying flow process of operating process such as gel-filtration are determined in the employing gel-filtration.Gel-filtration protein standard (available from SIGMA, article No.: MWGF 1000), the making of mark song is marked Qu Jianbiao Figure 10 according to the protein standard specification sheets.The gel-filtration result shows, V
0Be 43.49 mL, Ve is that 61.76 mL(Ve are the mobile phase volume that ultraviolet absorption peak uses when occurring), do not detect other ultraviolet absorption peaks.The molecular weight that calculates under the acetyl xylan esterase state of nature according to the mark song is 216 kDa.Adopt the molecular weight of SDS-PAGE electrophoresis (12%) acetyl xylan esterase list subunit, preparation such as the table 4 of SDS-PAGE gel use the Bio-Rad electrophoresis apparatus, and deposition condition is: 80V 45 min; 120V 45min.The electrophoresis sample boils after SDS-PAGE loading buffered, the thorough depolymerization of protein protomer.The result shows that its molecular weight is 36 kDa, such as Fig. 8, and swimming lane 2.This shows under the acetyl xylan esterase native state to be six aggressiveness forms.
3. the tripolymer of acetyl xylan esterase
Adopt SDS-PAGE electrophoresis (12%) that the acetyl xylan esterase (enzyme liquid 40 ℃ of temperature after SDS-PAGE loading buffered are bathed 5 min, and protein molecular is depolymerization not) of not depolymerization is analyzed other operation stepss such as above-mentioned SDS-PAGE electrophoresis.The result shows that the acetyl xylan esterase molecular weight is 107 kDa(such as Fig. 8, swimming lane 1).This exists with trimeric form after showing the acetyl xylan esterase electrophoresis, and it is tripolymer that certain material in the possible electrophoresis process in some conditioned disjunction electrophoresis solution makes six aggressiveness depolymerization.
SDS is a kind of sequestrant, can cause protein denaturation, may cause the depolymerization of six aggressiveness.Therefore, for whether checking is tripolymer because the SDS in the electrophoresis liquid makes natural six aggressiveness depolymerization, adopt native polyacrylamide gel electrophoresis and esterase dyeing to detect.Implementation process is as follows:
The preparation of solution: the preparation of gel is not added SDS such as table 4(); Tris – glycine electrophoretic buffer: 25 mmol/L Tris; 250 mmol/L glycine (pH 8.3); The loading buffering of sample buffer (0.1 mol/L Tris-Hcl, pH 6.8) 2*: add 1 mL glycerine and 0. 0001 g tetrabromophenol sulfonphthaleins in the Tris buffering (PH 6.8) of 0.5 mL, 1 mol/L, the distilled water of sterilization is diluted to 10 mL.After processing sample, add SDS, making its final concentration is 0.5 %, carries out electrophoresis after 40 ℃ of temperature are bathed 2 h, take the enzyme liquid sample that do not add SDS as blank.Use Bio-Rad vertical electrophoresis apparatus 80 V electrophoresis 45 min, 120 V electrophoresis, 45 min; Carry out afterwards esterase activity dyeing.The concrete steps of active coloring are as follows: accurately take by weighing 100 mg α-naphthylacetates and 100 mg β-naphthylacetates, fully dissolving adds 100 mg fast blues in 2 mL acetone, mixes.Be settled to 100 mL with 0.1 mol/L pH, 7.0 phosphoric acid buffers; Gel is put in the staining fluid, placed on the shaking table and slowly shake, 37 ℃, 55 turn, and 2 min dye.The result as shown in figure 11, the blank sample of processing without SDS is an esterase band, and the acetyl xylan esterase that adds SDS an other esterase band occurs below normal esterase band.This explanation is that SDS makes acetyl xylan esterase become tripolymer by six natural aggressiveness depolymerization, and 0.5% SDS is not enough so that the complete depolymerization of six aggressiveness.The concentration that strengthens SDS is 1%, and treat enzyme liquid 2 h carry out polyacrylamide gel electrophoresis and esterase dyeing, and it is tripolymer (such as Figure 12, swimming lane 1) that result such as Figure 12,1% SDS effect 2 h can make the basic fully depolymerization of six aggressiveness.
For determine trimerical activity and with the transformation relation of six aggressiveness, in esterase dyeing liquid, add 1% SDS and dye, guaranteeing that acetyl xylan esterase exists with tripolymer all the time in the esterase dyeing process, thereby determine trimerical esterase activity.The result shows that the tripolymer of acetyl xylan esterase has certain activity, but is lower than six aggressiveness (such as Figure 12, swimming lane 2).Gel is transferred in the staining fluid that does not contain SDS dyes, the result shows that (1 min) reverts to high reactivity in the acetyl xylan esterase short period of time, such as Figure 12, and swimming lane 3.This shows that SDS can make the acetyl xylan esterase depolymerization temporarily be tripolymer, and behind the flush away SDS, acetyl wood sugar esterase at short notice rapid autohemagglutination is combined into six aggressiveness.
The preparation of table 4. Native polyacrylamide gel electrophoresis gel
Solution | Separation gel | 12% (10 mL) | |
H 2O | 3.2 | 2.78 | |
30 % acrylamides | 4.0 | 0.66 | |
1.5 mol/L Tris-Hcl(PH8.8) | 2.6 | --- | |
1.0 mol/L Tris-Hcl(PH6.8) | --- | 0.5 | |
10% | 0.1 | 0.06 | |
10 % ammonium persulphates | 0.1 | 0.04 | |
TEMED | 0.01 | 0.01 |
The basic zymologic property research of present embodiment explanation restructuring acetyl xylan esterase.
1. the optimal reactive temperature of acetyl xylan esterase, optimal pH:
Take 4-methyl umbrella shape ethyl ester as substrate, detect optimal reactive temperature, the optimal pH of acetyl xylan esterase.1 enzyme unit alive (U) is defined as: under certain reaction conditions, per minute discharges the required enzyme amount of 1 μ L 4-methyl umbelliferone.
Concrete steps are as follows:
(1) making of 4-methyl umbrella shape ethyl ester enzyme activity mark song: the 4-methyl umbelliferone of preparation 0.1,0.15,0.2,0.25,0.3,0.35,0.4 mM, measure respectively its light absorption value under 354 nm.Result such as Fig. 9.
(2) mensuration of peak optimization reaction temperature: mix the phosphoric acid buffer (0.1 mol/L) and 280 μ L distilled water of 100 μ L pH 7.0,40 ℃ of preheating 10 min; Add 10 μ L enzyme liquid; Add 10 μ L, 100 mol/L 4-methyl umbrella shape ethyl esters (being dissolved in DMSO); Behind 30,40,45,50,55,60,70 ℃ of lower reaction 10 min, add 600 μ L, 50 mmol/L citric acids, survey the light absorption value under 354 nm.Typical curve according to Fig. 9 is scaled enzyme activity.The result is shown in Fig. 7 (a), and the peak optimization reaction temperature is 50 ℃.
(3) mensuration of peak optimization reaction pH: mix 100 μ L pH and be respectively 3.0,4.0,5.0,6.0,7.0,7.5,8.0,8.5,9,10,11,12 phosphoric acid buffer (0.1 mol/L) and 280 μ L distilled water, 40 ℃ of preheating 10 min; Other steps are described in (2).Typical curve according to Fig. 9 is scaled enzyme activity.The result is shown in Fig. 7 (c), and peak optimization reaction pH is 8.0.
2. the temperature of acetyl xylan esterase, pH stability:
Use pNPA to measure temperature, the pH stability of acetyl xylan esterase as substrate.
(1) temperature stability determination step: prepare 62 mL centrifuge tubes, add respectively the enzyme liquid of 2 mL purifying; Place 25-70 ℃ of water-bath, survey remaining pNPA enzyme activity at 0.5h, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 9 h, 12 h, 24 h respectively, and calculate relative activity.The result is shown in Fig. 7 (b), and the acetyl xylan esterase of restructuring remains at enzyme activity below 55 ℃ and reaches 5 days more than 80 %, only can stablize 4 h when being higher than 60 ℃.
(2) pH Stability Determination step: prepare 10 2 mL centrifuge tubes, put into the damping fluid of 1.9 mL pH 3-12, add respectively 100 μ L enzyme liquid.Survey remnant enzyme activity behind 40 ℃ of water-bath 1 h, and computational is to vigor.The result is shown in Fig. 7 (b), and the acetyl xylan esterase of restructuring is very stable in pH 7.0-11.0 scope, and is unstable under the acidic conditions.
Present embodiment explanation acetyl xylan esterase is to the hydrolytic activity of short chain fatty acid fat and acyl compounds.
This study tour the application of acetyl xylan esterase in hydrolysis short chain fatty acid fat and removal of acylation class reaction (p-NP acetic ester, p-NP butyric ester, five acyl glucoses, 4-methyl umbrella shape ethyl ester, α-naphthylacetate, β-naphthylacetate).Specific embodiments is as follows:
1. the enzyme activity determination of p-NP acetic ester, p-NP butyric ester: as implementing the mensuration of enzyme activity in the case 2.The results are shown in Table 5.
2. to the enzyme activity determination of 4-methyl umbrella shape ethyl ester: as implementing the experimental procedure in the case 4.The results are shown in Table 5.
3. to the enzyme activity determination of five acyl glucoses: 1 enzyme unit (U) that lives is defined as: under certain reaction conditions, per minute discharges the required enzyme amount of 1 μ L acetic acid.The concentration of acetic acid is detected by high performance liquid chromatography (Japanese to Shimadzu company, the C18 post).Testing conditions is as follows: flow velocity 0.6 mL/min, and the 0.1 % phosphoric acid of 93.5 %, the acetonitrile of 3.5 %, the ultraviolet method detects.
(1) making of acetate concentration typical curve: the acetum of preparation 0.1,0.2,0.4,0.6 g/L, the light absorption value under Liquid Detection 210 nm.The result as shown in Figure 6.
(2) to the enzyme activity determination of five acyl glucoses: five acyl glucose solution (being dissolved in the Tris-HCl damping fluid of pH 8.0), 10 min of 50 ℃ of preheating 490 μ L 2 mmol/L; Add 10 μ L enzyme liquid, blank group is distilled water, 50 ℃ of water-bath 10 min behind the mixing; Add 100 μ L, 0.33 mol/L sulphuric acid soln, termination reaction; The high-efficient liquid phase chromatogram technique analysis acetic acid content.By the vigor of standard curve determination acetyl xylan esterase shown in Figure 6 to five acyl glucoses.
The result is: the peak area of solution acetic acid under 210 nm detect is 0.504,0.468 mAU*min after the acetyl xylan esterase reaction of two 50 times of parallel dilutions; 0.486 mAU*min averages; calculating acetyl xylan esterase according to typical curve shown in 6 is 328.5 U/mL to the vigor of five acyl glucoses, is 896U/mg than vigor.
4. to the enzyme activity determination of α-naphthylacetate, β-naphthylacetate
Concrete steps to the enzyme activity determination of α-naphthylacetate, β-naphthylacetate are as follows:
(1) preparation of each solution: A substrate solution: 2 mmol/ L α-naphthylacetates, take by weighing and add 0. 1 mol/ L pH, 7.4 phosphate buffered saline buffers, 49 mL after 20 mg α-naphthylacetates (chemical pure) dissolve with 1 mL Virahol, jolting hydrotropy firmly, 4 ℃ keep in Dark Place available 1 week; 0. 1 mol/ L pH, 7.4 phosphate buffered saline buffers: 1.36 g KH
2PO
4Be dissolved in the 80 mL distilled waters, transfer pH to 7.4 with 1 mol/L NaOH, be settled to 100 mL; B stop buffer: 1. 75 mol/L acetic acid (11 mL Glacial acetic acid are diluted to 100mL); The C nitrite ion: the solid blue B salt of 1 mmol/ L, take by weighing the solid blue B (analytical pure) of 50 mg and add 0. 8% tween 20,100 mL, 4 ℃ keep in Dark Place available 2 weeks; The D reference liquid: 2 mmol/ L α-naphthols, water complements to 100 mL after taking by weighing 28. 8 mg α-naphthols (analytical pure) and adding dehydrated alcohol 0. 5 mL dissolving, and 4 ℃ keep in Dark Place.
(2) operation steps: get 3 1.5 mL centrifuge tubes, indicate respectively mensuration, standard, blank.In centrifuge tube, add 0.5 mL substrate solution, 50 μ L testing samples or reference liquid or distilled water, 40 ℃ of water-bath 20 min respectively; Take out respectively the reacted solution of 250 μ L, add 0.5 mL stop buffer and 0.5 mL nitrite ion, mixing, 40 ℃ of water-bath 20 min;
With the blank tube zeroing, read absorbancy under 520 nm.
(3) calculating of enzyme activity: measure pipe A/standard pipe A*100=α/β-naphthyl acetate esterase enzyme activity (U/L); The enzyme activity definition: it is 1 unit of enzyme activity (U/ L) that every liter of enzyme liquid produces 1 mol α/β-naphthols at 40 ℃ of enzyme reaction 1 min.
The vigor of the α/β that records-naphthylacetate sees Table 5.
Table 5. acetyl xylan esterase is to the hydrolytic activity of short chain fatty acid fat and acyl compounds
Substrate | Enzyme activity (U/mL) | Than vigor (U/mg) |
The p-NP acetic ester | 705.4 | 2949.4 |
The p-NP butyric ester | 0.65 | 1.8 |
4-methyl umbrella shape ethyl ester | 286.4 | 781.1 |
α-naphthylacetate | 195.3 | 532.7 |
β-naphthylacetate | 253.7 | 691.9 |
Five acyl glucoses | 328.5 | 896 |
Cephalosporin | 127.6 | 348 |
7-amino-cephalosporanic acid | 135.6 | 638.7 |
Present embodiment explanation restructuring acetyl xylan esterase is in the important intermediate of producing β-lactam antibitics---the application in the 7-amino-cephalosporanic acid of removal of acylation.
Acetyl xylan esterase can utilize 7-amino-cephalosporanic acid to be raw material, is converted into important intermediate---the 7-amino-cephalosporanic acid of β-lactam antibitics through removal of acylation.The present invention has tentatively probed into the removal of acylation enzyme activity of this novel acetyl xylan esterase to 7-amino-cephalosporanic acid.1 enzyme unit alive (U) is defined as: under certain reaction conditions, per minute discharges the required enzyme amount of 1 μ L acetic acid.
Concrete operation step is as follows:
(1) making of acetate concentration typical curve: as implementing the making of acetate concentration typical curve in the case 5.
(2) mensuration of 7-amino-cephalosporanic acid enzyme activity: 7-amino-cephalosporanic acid solution (being dissolved in the Tris-HCl damping fluid of pH 8.0) 10 min of 50 ℃ of preheating 490 μ L 2 mmol/L; Add 10 μ L enzyme liquid, blank group is distilled water, 50 ℃ of water-bath 10 min behind the mixing; Add 100 μ L, 0.33 mol/L sulphuric acid soln, termination reaction; The high-efficient liquid phase chromatogram technique analysis acetic acid content.Press standard curve determination acetyl xylan esterase shown in Figure 6 to five acyl glucose enzyme activities.
The result is: the peak area of solution acetic acid under 210 nm detect is 1.556,1.506 mAU*min after the acetyl xylan esterase reaction of two 10 times of parallel dilutions; 1.531 mAU*min average; calculating acetyl xylan esterase according to typical curve shown in 6 is 135.6 U/mL to five acyl glucose enzyme activities, is 638.7U/mg than vigor.
Present embodiment explanation Recombinant esterase is in the important intermediate of producing β-lactam antibitics---the application among the deacylated cephaloporins C.
Acetyl xylan esterase can utilize cephalosporin to be raw material, is converted into the cephalosporin of the important intermediate-removal of acylation of β-lactam antibitics through removal of acylation.The present invention has probed into the removal of acylation enzyme activity of this enzyme to cephalosporin.1 enzyme unit alive (U) is defined as: under certain reaction conditions, per minute discharges the required enzyme amount of 1 μ L acetic acid.
Concrete steps are with case study on implementation 7, the result is: the peak area of solution acetic acid under 210 nm detect is 1.417,1.406 mAU*min after the acetyl xylan esterase reaction of two 10 times of parallel dilutions, 1.4115 mAU*min average, calculating acetyl xylan esterase according to typical curve shown in 6 is 127.6 U/mL to the vigor of 7-amino-cephalosporanic acid, is 348 U/mg than vigor.
In sum; the dna sequence dna efficient soluble expression restructuring acetyl xylan esterase in Escherichia coli system that derives from subtilis of the present invention has widely substrate spectrum; can be hydrolyzed short chain fatty acid fat and multiple acylations compound; and the cephalosporin of the synthetic 7-amino-cephalosporanic acid of highly active catalytic and removal of acylation has huge application potential in the application facet of xylan degrading and β-lactam antibitics production.
Above-described embodiment is the better embodiment of the present invention; but embodiments of the present invention are not limited by above-described embodiment; other any do not deviate from change, the modification done under spirit of the present invention and the principle, substitutes, combination, simplify the substitute mode that all should be equivalence, is included in protection scope of the present invention.
Sequence table
<110〉Nanjing University of Technology
<120〉a kind of acetyl xylan esterase and application thereof
<130> NJUT121018
<160> 4
<170> PatentIn version 3.3
<210> 1
<211> 957
<212> DNA
<213> Bacillus subtilis
<220>
<221> CDS
<222> (1)..(957)
<400> 1
atg caa tta tac gac ttg ccg ctc gac caa ctg caa acc tat aaa cca 48
Met Gln Leu Tyr Asp Leu Pro Leu Asp Gln Leu Gln Thr Tyr Lys Pro
1 5 10 15
aat aaa acc gct cct cat gac ttt tcg gat ttt tgg gca tca tca tta 96
Asn Lys Thr Ala Pro His Asp Phe Ser Asp Phe Trp Ala Ser Ser Leu
20 25 30
cat gag ctt gca aag gaa gag gca aag cct gaa ttg aag gct gaa agc 144
His Glu Leu Ala Lys Glu Glu Ala Lys Pro Glu Leu Lys Ala Glu Ser
35 40 45
tac ccg gct gac ggc gtg aaa gta ttc cgg ctg aca tac cgt agc ttc 192
Tyr Pro Ala Asp Gly Val Lys Val Phe Arg Leu Thr Tyr Arg Ser Phe
50 55 60
ggc aag gcg gaa att gag gga tgg tac gcc gtt ccc gac cgg caa gga 240
Gly Lys Ala Glu Ile Glu Gly Trp Tyr Ala Val Pro Asp Arg Gln Gly
65 70 75 80
ccg cat ccg gcc atc gtg aaa tat cac ggc tat aac gcg agc tat gac 288
Pro His Pro Ala Ile Val Lys Tyr His Gly Tyr Asn Ala Ser Tyr Asp
85 90 95
ggg gat ata cat gac atc gta aat tgg gcg ctt cac gga tat gcc gcg 336
Gly Asp Ile His Asp Ile Val Asn Trp Ala Leu His Gly Tyr Ala Ala
100 105 110
ttc ggc atg ctt gtc cgc ggc cag cac agc agc aca gat aca agc gtc 384
Phe Gly Met Leu Val Arg Gly Gln His Ser Ser Thr Asp Thr Ser Val
115 120 125
tca ccg cac gga cac gtt ccc ggc tgg atg acg aaa ggg att tta gat 432
Ser Pro His Gly His Val Pro Gly Trp Met Thr Lys Gly Ile Leu Asp
130 135 140
aaa gat aca tat tat tac cgc ggc gtg tac tta gac gcc gtc cgg gct 480
Lys Asp Thr Tyr Tyr Tyr Arg Gly Val Tyr Leu Asp Ala Val Arg Ala
145 150 155 160
ttg gaa gtc atc agc ggc ttt gat gaa gtg gat gaa acg agg atc gcc 528
Leu Glu Val Ile Ser Gly Phe Asp Glu Val Asp Glu Thr Arg Ile Ala
165 170 175
gtc atc ggc ggg agc cag gga ggc gga ctt tca atc gct gcg gcg gca 576
Val Ile Gly Gly Ser Gln Gly Gly Gly Leu Ser Ile Ala Ala Ala Ala
180 185 190
cta tct gat att ccg aga gcg gtt gcg gcc gat tat cct tat tta agc 624
Leu Ser Asp Ile Pro Arg Ala Val Ala Ala Asp Tyr Pro Tyr Leu Ser
195 200 205
aat ttt gag cgg gcc att gat gtt gct ctt gat gag ccg tat ctt gag 672
Asn Phe Glu Arg Ala Ile Asp Val Ala Leu Asp Glu Pro Tyr Leu Glu
210 215 220
att aac tcc ttt ttc aga aag aac ggc agc cct gaa acg gag aag acc 720
Ile Asn Ser Phe Phe Arg Lys Asn Gly Ser Pro Glu Thr Glu Lys Thr
225 230 235 240
gcg atg aat aca ctg gcc tat ttt gat atc atg aat ctg gcg gac cgc 768
Ala Met Asn Thr Leu Ala Tyr Phe Asp Ile Met Asn Leu Ala Asp Arg
245 250 255
gta aaa gtt ccg gtg ctc atg tcc atc ggg ctg att gac cgc gtg act 816
Val Lys Val Pro Val Leu Met Ser Ile Gly Leu Ile Asp Arg Val Thr
260 265 270
ccg ccg tcg acg gtg ttt gcc gct tac aat cat ctg gaa acg gaa aaa 864
Pro Pro Ser Thr Val Phe Ala Ala Tyr Asn His Leu Glu Thr Glu Lys
275 280 285
caa ttg aag gtt tac cgg tat ttc gga cat gaa tac ata cct tct ttc 912
Gln Leu Lys Val Tyr Arg Tyr Phe Gly His Glu Tyr Ile Pro Ser Phe
290 295 300
cat acg gaa aag ctg gcc ttt ctg aaa gcg cat ctg aaa ggc tga 957
His Thr Glu Lys Leu Ala Phe Leu Lys Ala His Leu Lys Gly
305 310 315
<210> 2
<211> 318
<212> PRT
<213> Bacillus subtilis
<400> 2
Met Gln Leu Tyr Asp Leu Pro Leu Asp Gln Leu Gln Thr Tyr Lys Pro
1 5 10 15
Asn Lys Thr Ala Pro His Asp Phe Ser Asp Phe Trp Ala Ser Ser Leu
20 25 30
His Glu Leu Ala Lys Glu Glu Ala Lys Pro Glu Leu Lys Ala Glu Ser
35 40 45
Tyr Pro Ala Asp Gly Val Lys Val Phe Arg Leu Thr Tyr Arg Ser Phe
50 55 60
Gly Lys Ala Glu Ile Glu Gly Trp Tyr Ala Val Pro Asp Arg Gln Gly
65 70 75 80
Pro His Pro Ala Ile Val Lys Tyr His Gly Tyr Asn Ala Ser Tyr Asp
85 90 95
Gly Asp Ile His Asp Ile Val Asn Trp Ala Leu His Gly Tyr Ala Ala
100 105 110
Phe Gly Met Leu Val Arg Gly Gln His Ser Ser Thr Asp Thr Ser Val
115 120 125
Ser Pro His Gly His Val Pro Gly Trp Met Thr Lys Gly Ile Leu Asp
130 135 140
Lys Asp Thr Tyr Tyr Tyr Arg Gly Val Tyr Leu Asp Ala Val Arg Ala
145 150 155 160
Leu Glu Val Ile Ser Gly Phe Asp Glu Val Asp Glu Thr Arg Ile Ala
165 170 175
Val Ile Gly Gly Ser Gln Gly Gly Gly Leu Ser Ile Ala Ala Ala Ala
180 185 190
Leu Ser Asp Ile Pro Arg Ala Val Ala Ala Asp Tyr Pro Tyr Leu Ser
195 200 205
Asn Phe Glu Arg Ala Ile Asp Val Ala Leu Asp Glu Pro Tyr Leu Glu
210 215 220
Ile Asn Ser Phe Phe Arg Lys Asn Gly Ser Pro Glu Thr Glu Lys Thr
225 230 235 240
Ala Met Asn Thr Leu Ala Tyr Phe Asp Ile Met Asn Leu Ala Asp Arg
245 250 255
Val Lys Val Pro Val Leu Met Ser Ile Gly Leu Ile Asp Arg Val Thr
260 265 270
Pro Pro Ser Thr Val Phe Ala Ala Tyr Asn His Leu Glu Thr Glu Lys
275 280 285
Gln Leu Lys Val Tyr Arg Tyr Phe Gly His Glu Tyr Ile Pro Ser Phe
290 295 300
His Thr Glu Lys Leu Ala Phe Leu Lys Ala His Leu Lys Gly
305 310 315
<210> 3
<211> 26
<212> DNA
<213> Artificial
<220>
<223〉according to the upstream primer of Cah gene design
<400> 3
tatacatatg caattatacg acttgc 26
<210> 4
<211> 27
<212> DNA
<213> Artificial
<220>
<223〉according to the downstream primer of Cah gene design
<400> 4
ggaattcctc agcctttcag atgcgct 27
Claims (5)
1. an acetyl xylan esterase is characterized in that it has the aminoacid sequence shown in the SEQ ID NO:2.
2. acetyl xylan esterase according to claim 1 is characterized in that its protein structure is homo-hexamer or homotrimer.
3. the expression vector that comprises the encoding gene of the described acetyl xylan esterase of claim 1.
4. a method for preparing acetyl xylan esterase claimed in claim 1 is characterized in that: transform Host Strains with expression vector claimed in claim 3, abduction delivering acquisition restructuring acetyl xylan esterase.
5. acetyl xylan esterase claimed in claim 1 is in hydrolysis short chain fatty acid fat, removal of acylation reaction, the 7-amino-cephalosporanic acid of producing removal of acylation and the application among the deacylated cephaloporins C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210403666.2A CN102952787B (en) | 2012-10-22 | 2012-10-22 | Acetylxylan esterase and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210403666.2A CN102952787B (en) | 2012-10-22 | 2012-10-22 | Acetylxylan esterase and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102952787A true CN102952787A (en) | 2013-03-06 |
CN102952787B CN102952787B (en) | 2014-07-16 |
Family
ID=47762174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210403666.2A Active CN102952787B (en) | 2012-10-22 | 2012-10-22 | Acetylxylan esterase and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102952787B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104762334A (en) * | 2015-04-15 | 2015-07-08 | 南京工业大学 | Method for producing peroxyacetic acid through enzymatic catalytic reaction |
CN106422963A (en) * | 2016-09-09 | 2017-02-22 | 南京工业大学 | Application of acetyl xylan esterase (AXE) as emulsifying agent |
CN111254152A (en) * | 2020-03-27 | 2020-06-09 | 广东药科大学 | Acetyl xylan esterase gene, its coding product and preparation method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999038982A1 (en) * | 1998-01-28 | 1999-08-05 | Biochemie Gesellschaft Mbh | Nucleic acid molecule encoding a cephalosporin acetylesterase |
JP2001510037A (en) * | 1997-07-15 | 2001-07-31 | ジェネンコア インターナショナル インコーポレーテッド | Proteases from Gram-positive microorganisms |
EP2121951A1 (en) * | 2006-12-12 | 2009-11-25 | E.I. Du Pont De Nemours And Company | Production of peracids using an enzyme having perhydrolysis activity |
-
2012
- 2012-10-22 CN CN201210403666.2A patent/CN102952787B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001510037A (en) * | 1997-07-15 | 2001-07-31 | ジェネンコア インターナショナル インコーポレーテッド | Proteases from Gram-positive microorganisms |
WO1999038982A1 (en) * | 1998-01-28 | 1999-08-05 | Biochemie Gesellschaft Mbh | Nucleic acid molecule encoding a cephalosporin acetylesterase |
EP2121951A1 (en) * | 2006-12-12 | 2009-11-25 | E.I. Du Pont De Nemours And Company | Production of peracids using an enzyme having perhydrolysis activity |
Non-Patent Citations (1)
Title |
---|
YP_001419972.1: "Cah [Bacillus amyloliquefaciens FZB42]", 《NCBI》, 2 November 2011 (2011-11-02) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104762334A (en) * | 2015-04-15 | 2015-07-08 | 南京工业大学 | Method for producing peroxyacetic acid through enzymatic catalytic reaction |
CN106422963A (en) * | 2016-09-09 | 2017-02-22 | 南京工业大学 | Application of acetyl xylan esterase (AXE) as emulsifying agent |
CN111254152A (en) * | 2020-03-27 | 2020-06-09 | 广东药科大学 | Acetyl xylan esterase gene, its coding product and preparation method |
CN111254152B (en) * | 2020-03-27 | 2023-06-23 | 广东药科大学 | Acetylxylan esterase gene, coded product and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102952787B (en) | 2014-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Denison et al. | Cellulase activity of Poronia oedipus | |
Zhu et al. | Purification and characterization of a new κ-carrageenase from the marine bacterium Vibrio sp. NJ-2 | |
Menon et al. | Enzymatic hydrolysis and ethanol production using xyloglucanase and Debaromyces hansenii from tamarind kernel powder: galactoxyloglucan predominant hemicellulose | |
Park et al. | Enhancing the production of Rhodobacter sphaeroides-derived physiologically active substances using carbonic anhydrase-immobilized electrospun nanofibers | |
CN102952787B (en) | Acetylxylan esterase and application thereof | |
CN105274081A (en) | D-acetylglucosamine deacetylase heterologous expression and application | |
CN103013960A (en) | Alkaline protease and recombinant expression engineering bacterium thereof | |
Vitcosque et al. | The functional properties of a xyloglucanase (GH12) of Aspergillus terreus expressed in Aspergillus nidulans may increase performance of biomass degradation | |
CN109280673B (en) | Glycoside hydrolase family 7 protein gene, protein coded by same and application of protein | |
CN111500554A (en) | Preparation and application of high-activity β -xylosidase | |
CN102154239A (en) | New gene of beta-galactosidase with high glycosyl transfer efficiency and application thereof | |
CN103614303B (en) | A kind of Li's Trichoderma strains of expressing saccharifying enzyme | |
CN103352031B (en) | Glycosyltransferase gene and application thereof | |
Takagi et al. | Polygalactosamine produced by a microorganism | |
CN103695405A (en) | Novel beta-lactam antibiotic synthetase production method | |
CN110438176A (en) | With the gene estDR4 of esterase function and its application | |
Chow et al. | A 1, 3-1, 4-β-glucan utilization regulon in Paenibacillus sp. strain JDR-2 | |
CN111551513B (en) | Method for rapidly determining content of hyaluronic acid in fermentation liquor | |
Singhania | Beta-Glucosidase from Aspergillus niger NII 08121-Molecular characterization and applications in Bioethanol production | |
Liang et al. | Secretory production and characterization of a highly effective chitosanase from Streptomyces coelicolor A3 (2) M145 in Pichia pastoris | |
CN108517348B (en) | DNA-based kit for visually detecting alkaline phosphatase | |
CN106148313B (en) | A kind of immobilization cephalosporin C acrylase and preparation method thereof | |
CN102517265B (en) | Esterase, and preparation method and application thereof | |
CN105483111A (en) | Immobilization lipase and preparation method thereof | |
CN104502612A (en) | Turbidimetry method for specifically detecting beta-glucan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |